Jan 29 (Reuters) - * APIMEDS PHARMACEUTICALS US INC - IPO PRICE RANGE EXPECTED BETWEEN $4.00 AND $5.00 * APIMEDS PHARMACEUTICALS US INC SEES IPO OF UP TO 4.5 MILLION SHARES OF COMMON STOCK Source text: Further company coverage: [ ] ...

By Yadarisa Shabong (Reuters) - Detroit-based American Axle and Manufacturing ( AXL ) will buy GKN Automotive owner Dowlais ( DWLAF ) in a cash-and-stock deal, valuing the London-listed firm at about 1.16 billion pounds ($1.44 billion), the companies said on Wednesday. Dowlais ( DWLAF ) shares jumped as much as 13%, but had pared gains to trade up 4.6%...

(Reuters) - Levi Strauss forecast annual profit well below analysts' estimates, taking a cautious stance despite a strong holiday quarter and sending its shares down about 8% in extended trading on Wednesday. The company's struggling U.S. wholesale business returned to revenue growth after six quarters of decline, as newness in its collections, including men's apparel, attracted demand from retailers. Still,...

(Reuters) -Meta Platforms beat Wall Street expectations for fourth-quarter revenue on Wednesday but predicted sales in the current first quarter may not meet forecasts, sending mixed signals about how its bets on pricey artificial intelligence-powered tools are paying off. The Facebook and Instagram parent company expects first quarter revenue between $39.5 billion and $41.8 billion, compared with analysts' average estimate...